Key result
Being homozygous for the 2G allele of the MMP-1 gene was associated with a reduced risk of coronary heart disease compared to the 1G allele.
Why the study?
Matrix metalloproteinase-1 gene expression may influence the development and progression of atherosclerotic plaques, but its association with coronary heart disease risk in humans was unclear.
Does the 1G/2G polymorphism in the MMP-1 gene or the 5A/6A polymorphism in the MMP-3 gene affect the risk of coronary heart disease in older Caucasian adults?
Observational (n=471)
No
Does the 1G/2G polymorphism in the MMP-1 gene or the 5A/6A polymorphism in the MMP-3 gene affect the risk of coronary heart disease in older Caucasian adults?
Answers are grounded in this paper and cite their sources.
The 2G allele of the MMP-1 gene is associated with a reduced risk of coronary heart disease, suggesting a genetic role in human atherogenesis.
AIMS: Matrix metalloproteinase-1 (MMP-1), a proteolytic enzyme able to degrade types I and III collagens, is present in atherosclerotic lesions but absent from the normal blood vessel wall. The recent observation that, in a transgenic mouse model, MMP-1 gene expression slows the development and progression of atherosclerotic plaques suggests that it may play a role in human atherogenesis. We investigated whether coronary heart disease was associated with a functional polymorphism in the human MMP-1 gene. In addition, we examined a polymorphism in the human MMP-3 gene that was previously reported to be associated with progression of coronary atherosclerosis. METHODS AND RESULTS: We genotyped 471 Caucasian men and women, aged 66-75 years, from Sheffield, UK, for the 1G/2G polymorphism in the MMP-1 gene and the 5A/6A polymorphism in the MMP-3 gene and ascertained the prevalence of coronary heart disease. People homozygous for the more transcriptionally active 2G allele of the MMP-1 gene had a reduced risk of coronary heart disease (OR 0.5, 95% CI 0.3 to 0.9) compared to people homozygous for the less transcriptionally active 1G allele. Heterozygotes had an intermediate risk (OR 0.7, 95% CI, 0.5 to 1.1). We found no association between the 5A/6A polymorphism in the MMP-3 gene and risk of coronary heart disease. CONCLUSION: Sequence variants at the MMP-1 genomic locus may influence risk of coronary heart disease in humans.
No takes yet. Share an insight, caveat, or question.
Shu Ye (2003) conducted an observational in coronary heart disease (n=471). Homozygous 2G allele of the MMP-1 gene vs. Homozygous 1G allele of the MMP-1 gene was evaluated on coronary heart disease (OR 0.5, 95% CI 0.3 to 0.9). Being homozygous for the 2G allele of the MMP-1 gene was associated with a reduced risk of coronary heart disease compared to the 1G allele.
Synapse has enriched 10 related papers. Consider them for comparative context: